Catastrophic primary central nervous system vasculitis

Clinical and Experimental Rheumatology

Volumn 32, Issue SUPPL.82, 2014, Pages

  Salvarani, Carlo ^a   Brown, Robert D ^b   Morris, Jonathan M ^b   Huston, John ^b   Hunder, Gene G ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b MAYO CLINIC   (United States)

Author keywords

Infarcts; Large vessels; Primary central nervous system vasculitis

Indexed keywords

CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE;

ADULT; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN INFARCTION; BRAIN VASCULITIS; CASE REPORT; DEATH; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG PULSE THERAPY; ERYTHROCYTE SEDIMENTATION RATE; GENERAL CONDITION DETERIORATION; HEMIPARESIS; HUMAN; LETHARGY; MALE; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

BRAIN INFARCTION; CEREBRAL ANGIOGRAPHY; CYCLOPHOSPHAMIDE; DISEASE PROGRESSION; FATAL OUTCOME; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; METHYLPREDNISOLONE; MIDDLE AGED; NEUROPROTECTIVE AGENTS; POSITRON-EMISSION TOMOGRAPHY; VASCULITIS, CENTRAL NERVOUS SYSTEM;

EID: 84901949083     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Le GUENNEC L, ROOS-WEIL D, MOKHTARI K et al.: Granulomatous angiitis of the CNS revealing a Hodgkin lymphoma. Neurology 2013; 80: 323-4.
2. SALVARANI C, BROWN RD Jr, HUNDER GG: Adult primary central nervous system vasculitis. Lancet 2012; 380: 767-77.
3. SALVARANI C, BROWN RD Jr, CALAMIA KT et al.: Rapidly progressive primary central nervous system vasculitis. Rheumatology (Oxford) 2011; 50: 349-58.
4. SALVARANI C, BROWN RD, MORRIS JM, HUSTON J 3rd, HUNDER GG: Unilateral chronic relapsing primary central nervous system vasculitis. Clin Exp Rheumatol 2014 32 (Suppl. 82): S139.
5. PIPITONE N, OLIVIERI I, SALVARANI C; ItaliIan SociIety of Rrheumatology: Recommendations of the Italian Society of Rheumatology for the treatment of the primary large-vessel vasculitis with biological agents. Clin Exp Rheumatol 2012; 30 (Suppl. 70): S139-61.